The COVID-19 pneumonia broke out at the end of 2019 and rapidly swept the world due to its extremely high infectivity. Taiwan also suffered from COVID-19 epidemic since this May. The epidemic forced the physicians to identify severe, moderate, and mild patients as soon as possible to ensure that medical resources can be used with maximum efficiency. In addition, we should think about the ways to participate in disease control under the threat of highly contagious diseases with inappropriate traditional Chinese medicine diagnosis model of Wang, Wen, Wen, Qi. This case was a 68-year-old man with multiple chronic diseases. He went to the emergency room for fever and dyspnea. After screening, he was diagnosed as COVID-19 pneumonia. He was classified as a severe case since his had chronic diseases and the initial oxygen saturation in the room air was 93%. The treatment of severe cases included steroids, Interleukin-6 Inhibitors (IL-6 inhibitor), antibiotics and Remdesivir, and the patient received combined treatment with Taiwan Chingguan Yihau (NRICM101) when admitted to the intensive care unit. Fever subsided the next day after being hospitalized, and the symptoms were all improved within 10 days. With this case, we will discuss the applicability of NRICM101 in COVID-19 pneumonia patients.
【Keywords】
COVID-19 pneumonia； Severe COVID-19 infection； Taiwan Chingguan Yihau (NRICM101)； Case report
25S.16 运用清冠一号於COVID-19病例报告
